This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Antroquinonol administration in animal preclinical studies for Alzheimer's disease (AD): A new avenue for modifying progression of AD pathophysiology.
Brain, behavior, & immunity - health, 21, 100435
Citation
Francesca, Fernandez; Caitlin, Aust; Sarah, Lye; Robyn, Griffiths Lyn. (2022). Antroquinonol administration in animal preclinical studies for Alzheimer's disease (AD): A new avenue for modifying progression of AD pathophysiology.. Brain, behavior, & immunity - health, 21, 100435. https://doi.org/10.1016/j.bbih.2022.100435